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Abstract
Investigation employing bronchoalveolar lavage supports both increased and decreased iron
concentrations in the epithelial liningfluid (ELF) of smokers. Exhaled breath condensate (EBC) is an
alternative approach to sampling the ELF.We evaluated for an association between iron homeostasis
and both smoking and a diagnosis of chronic obstructive pulmonary disease (COPD) bymeasuring
metal concentrations in EBC samples fromnon-smoker controls, smoker controls, and individuals
diagnosedwithCOPD. The total number of EBC specimens was 194. EBC iron and zinc
concentrations (mean±standard error) in the total study populationwere 0.610±0.025 and
40.73±1.79 ppb respectively. In linear regressions, total cigarette smoking in pack years showed a
significant (negative) relationshipwith EBC iron concentration but notwith EBC zinc concentration.
Iron concentrations in EBC fromGOLD stage II, III, and IV patients were all significantly decreased
relative to those fromnon-smoker and smoker controls. In contrast to iron, zinc concentrations in
EBCwere not significantly different than those fromnon-smoker and smoker controls. It is concluded
that smoking decreases EBC iron concentrations and patients diagnosedwithCOPDhave significantly
lower EBC iron concentrations. These results likely reflect an increased burden of cigarette smoke
particles in the lower respiratory tract of ever-smokers and patients withCOPD and the capacity of
components in this particle to complex iron.
Introduction
Chronic obstructive pulmonary disease (COPD)most
frequently refers to some combination of chronic
bronchitis and emphysema, a pair of commonly co-
existing lung diseases [1, 2]. COPD is characterized by
a physiologic limitation of the expiratory flow of air
from the lungs which is irreversible. The natural
course of the disease can include a gradual worsening
of obstruction over years with exacerbations of airflow
obstruction often caused by infections and air pollu-
tion. The vastmajority of COPD in theUnited States is
the result of cigarette smoking.
A disruption in iron homeostasis with con-
comitant accumulation of the metal has been pro-
posed to contribute to COPD associated with cigarette
smoking [3, 4]. Smoking a single cigarette exposes the
human respiratory tract to between 150 00 and
400 00 μg particulate matter with a high rate of
deposition in the human lung [5]. Incomplete oxida-
tion of tobacco leaves produces oxygen-containing
functional groups (e.g. carboxylates and phenolic
hydroxides) at the surface of the retained cigarette
smoke particles [6]. Following dissociation of protons
at the physiological pH level, these functional groups
introduce a negatively charged solid–liquid interface
into the lung tissue. Iron (III) has a high affinity
toward oxygen-donor ligands due to its electro-
positivity, and thus, it forms complexes with the parti-
culate matter deposited from cigarette smoking [7].
Subsequently, these complexes of iron with cigarette
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EBC collection was carried out as described pre-
viously [14]. All subjects were asked to refrain from
eating, drinking, and smoking for at least 3 h prior to
sample collection. EBC samples were collected during
tidal breathing for 10 min using the RTubeTM
(Respiratory Research Inc., Charlottesville, Virginia)
and aliquoted for storage at 70 °C. Available data did
not include either EBC volume or duration of
collection.
Measurement of iron and zinc concentrations
in EBC
The concentration of 56Fe (iron) and 64Zn (zinc) in
EBC was determined by inductively coupled plasma-
mass spectrometry (ICP-MS; ELANDRC II, PerkinEl-
mer, Waltham, MA). The analyses were carried out
using nickel cones, a quartz cyclonic spray chamber,
and a Meinhard Type A quartz nebulizer. Instrument
conditions were: 1400W RF power, nebulizer gas flow
of 1.08 l min−1, pump sample flowrate of 1 ml min−1,
1000 ms dwell time per isotope, and 5 replicates per
measurement.
EBC samples (500 μl) were diluted with 2.0 ml
nitric acid (Fisher Optima A467), andmanually spiked
with 6.25 ppb indium (In) internal standard (Part
number LIS6020, VHG Labs, Manchester, NH). To
minimize polyatomic interferences, 56Fe was deter-
mined using dynamic reaction cell (DRC) mode. The
DRC was operated with 0.9 ml min−1 of ammonia gas
and cell settings of RPq=0.75 and RPa=0.00. 64Zn
was determined in standard analysis mode. Analysis
closely followed EPA Method 200.8rev5.4 [15]. Cali-
bration (Catalog number CL-CAL-2, Spex CertiPrep,
Metuchen, NJ) and quality control (Catalog numbers
44CS1Y and 44CS2Z, VHG Labs) stock standard solu-
tions were diluted with a 2% acid blank solution that
was matrix-matched with the diluted EBC samples.
Data were collected, processed and analyzed with
ELAN software v3.4. Calibration curve r2 values were
0.9996 for 56Fe and 0.9999 for 64Zn. The instrument
detection limits for 56Fe and 64Zn were 0.7 and 0.03
ppt while the method detection limits were 11 and
2 ppt.
Metal concentrations are expressed in units of
absolute concentration and not normalized to any
index to account for dilution. It was elected to com-
municate results in parts per billion without normal-
ization for purposes of comparison to other studies
focused on EBC. In addition, measurements of pro-
tein, albumin, and creatine to normalize the metal
concentrationwere of uncertain value.
Statistics
Data are expressed as mean values±standard devia-
tion (SD) unless specified otherwise. Differences
between two and multiple groups were compared
using T-tests of independent means and one-way
analysis of variance respectively; the post-hoc test
[8, 9]. Elevated iron concentrations can be observed 
not only in the lower respiratory tract but systemically 
as well [10]. Reflecting this disruption in the home-
ostasis of iron and its accumulation, serum concentra-
tions of ferritin, a metal storage protein, also increase 
in cigarette smokers [8].
Exhaled breath condensate (EBC) is an alternative 
approach to sampling the epithelial lining fluid (ELF). 
Investigation employing bronchoalveolar lavage sup-
ports both increased and decreased iron concentra-
tions in the ELF (i.e. the alveolar and airway lining 
fluids) of smokers [10–12]. A prior EBC study has sug-
gested lower levels of iron among patients with COPD; 
methodology employed to measure iron in this study 
used a bleomycin assay which reflects pro-oxidant 
levels rather than an absolute concentration of the 
metal [13]. We evaluated for an association between 
iron homeostasis in both ever-smokers and the diag-
nosis of COPD by measuring metal concentrations in 
EBC samples from non-smoker controls, smoker con-
trols, and patients diagnosed to have COPD.
Methods
Samples of EBC
EBC was collected in the ‘Evaluation of COPD long-
itudinally to identify predictive surrogate end-points’ 
(ECLIPSE) study, a 3 year longitudinal investigation 
with the overall objective of identifying the parameters 
predictive of disease progression in individuals with 
COPD. These samples included non-smoker controls, 
smoker controls, and GOLD stage II, III, and IV 
COPD patients. Non-smoker controls were male/
female subjects aged 40–75 years who (1) were free 
from significant disease as determined by history and 
physical examination, (2) had baseline post-broncho-
dilator FEV1 > 85% of the reference value and 
FEV1/FVC>0.7, and (3) had a total smoking history 
of <1 pack-year. Smoker controls were male/female 
subjects aged 40–75 years who (1) were free from 
significant disease as determined by history, physical 
examination and screening investigations, (2) had 
baseline post-bronchodilator FEV1 > 85% of the 
reference value and FEV1/FVC> 0.7, and (3) were
current or ex-smokers with a smoking history 10
pack-years. Non-smoker controls and smoker con-
trols were recruited through site databases and other 
methods (advertisements in local newspapers and 
television/radio stations). COPD patients were male/
female subjects aged 40–75 years who (1) had baseline 
post-bronchodilator FEV1 < 80% of the reference 
value and FEV1/FVC0.7, and (2) were current or 
ex-smokers with a smoking history of 10 pack-years. 
GOLD stage II, III, and IV were defined as:
50%FEV1<80%, 30%FEV1<50%, and 
FEV1< 30% predicted respectively. COPD patients 
were recruited from the outpatient clinics of the 46 
participating centers.
employed was Duncan’s multiple range test. Pearson
product-moment correlation coefficients were calcu-
lated. Two-tailed tests of significance were employed.
Significancewas assumed at p<.05.
Results
The total number of EBC specimens was 194. The
individuals with COPD (GOLD stage II, III, and IV)
were significantly older than the non-smoker controls
and the smoker controls (table 1). The percentage of
females in each group varied widely. All but three
patients were Caucasian. Non-smoker controls and
smoker controls smoked less than the COPD patients
(F=4.04, p=0.004; table 2). There were no signifi-
cant differences in pack years smoking among GOLD
stage II, III, and IVCOPDpatients.
EBC iron and zinc concentrations (mean±-
standard error) in the total study population were
0.610±0.025 and 40.73±1.79 ppb respectively.
The percentage relative standard deviation for mea-
surements of 56Fe and 64Znwere20% in 94.6% and
100% of the samples respectively. Linear regressions
between (1) age and iron concentrations and (2) age
and zinc concentrations showed no significant rela-
tionships (r=0.093; p=0.24 and r=0.024;
p=0.81 respectively). Similarly, gender did not
impact EBC iron and zinc concentrations (T=0.285
and p=0.78 and T=0.514 and p=0.61 respec-
tively). Total cigarette smoking in pack years did show
a negative relationship with EBC iron (r=0.201;
p=0.009) but not with EBC zinc concentration
(r=0.088; p=0.270) (figure 1).
Iron concentrations in the EBC from GOLD stage
II, III, and IV patients were all significantly decreased
relative to those from non-smoker and smoker con-
trols (F=3.594, p=0.007; figure 2(A)) Zinc con-
centrations were greater than iron with the ratio of
zinc to iron concentrations varying from 34 to 95
among the groups (figure 1(B)). In contrast to iron,
zinc concentrations in EBC from non-smoker con-
trols were not significantly different than those from
smoker controls, and Gold stage II, III, and IV patients
(F=1.488, p=0.2076; figure 2(B)). EBC iron and
zinc concentrations correlated positively (r=0.32;
p<.0001) (figure 3).
Discussion
In prior investigation, levels of metals (i.e. manganese,
chromium, nickel and chromium) in EBC were
affected by gender [16]. These disparities between
genders, and those proposed to occur with aging, can
reflect the volume of collected condensate which is
proportional to the ventilatory volume (pulmonary
function is determined by gender, age, and height/
weight). However, gender and age did not impact EBC
iron and zinc concentrations in this study of ELIPSE
subjects.
Tobacco smoke includes numerous metals in sig-
nificant concentrations [17]. Subsequently, smoking
can impact metals concentrations in EBC [12, 16,
18–21]. Healthy smokers were previously demon-
strated to have higher EBC concentrations of lead and
cadmium relative to healthy non-smokers [22]. Cad-
mium, lead, and aluminum levels in EBC were also
observed to be higher among both smokers and smo-
kers with COPD [23].When patients with COPDwere
subdivided into smokers versus ex-smokers and non-
smokers, smokers were shown to have higher EBC
lead, cadmium, and aluminum levels [12]. Ex-smo-
kers with COPD who had quit smoking for more than
2 years continued to show elevations in EBC metals
relative to non-smokers [22]. Regarding iron, both
tobacco leaf and tobacco smoke include this specific
metal and smoking can be predicted to introduce
some quantity into the respiratory tract [17, 24]. Iron
concentrations in EBC, measured using a bleomycin
assay, were previously observed to be significantly
increased in smokers when compared to healthy con-
trols [25]. However, reduced concentrations of iron
(as well as nickel) have also been observed in the EBC
of smokers [12, 19]. In our cohort of 194 EBC samples
obtained from the ECLIPSE study, regression showed
that smoking was associated with decreased iron con-
centration in the EBC. This effect of smoking on EBC
iron concentration is attributed to coordination of the
metal by retained smoke particle. There is a large mass
of particle which is retained in the lung with smoking.
The incomplete combustion of tobacco leaf produces
humic-like substances (HULIS) [9]. As a result of pos-
sessing a variety of oxygen-containing functional
groups (e.g. phenolic and carboxylate groups), HULIS
complex metal cations [26–28]. The high content of
oxygen-containing functional groups in HULIS favors
the formation of stable complexes with metals but the
sorption ability of iron is greatest among all of them
[29]. Accordingly, cigarette smoking introduces
HULIS into the human lung where it disrupts iron
homeostasis. Despite an accumulation of iron by the
particle, an intracellular iron deficiency can be evident
Table 1.Characterization of the study population.
Group N Age (years) Gender Ethnicity
Non-smoker
controls





16 59.1±6.8 2 females 16Caucasian
Gold stage II 52 65.4±6.2 22 females 52Caucasian




Gold stage IV 46 63.3±5.9 4 females 46Caucasian
Table 2. Smoking histories of the study population.
Group Ex-smokers Current smokers Pack years smoking
Non-smoker controls 0 0 0
Smoker controls 16 0 27.6±19.5
Gold stage II 34 18 53.8±34.9
Gold stage III 30 20 47.7±28.2
Gold stage IV 12 34 54.4±28.2
Figure 1.Correlations of pack years cigarette smokingwith EBC concentration of iron. There was a significant decrease in EBC iron
with pack years cigarette smoking (p=.03).
Figure 2.EBC concentrations of iron (A) and zinc (B) in non-smoker controls, smoker controls, Gold stage II, Gold stage III, andGold
stage IV subjects. There are decreased concentrations of EBC iron among those individuals withGold stage II, Gold stage III, andGold
stage IV disease relative to non-smoker controls and smoker controls. *decreased relative to non-smoker controls.
with increased cell import of this metal following
uptake of the particle by macrophages and epithelial
cells [8]. Accordingly, the ELF iron is proposed to be
diminished in smokers as it functions as a source of the
metal for cells in the lower respiratory tract with endo-
cytosed particle. However, when the data was eval-
uated categorically, smoker controls were not
demonstrated to have a significantly lower EBC iron
concentration relative to that concentration in non-
smoker controls. This seeming contradiction can be
attributed to decreased total smoking in the smoker
controls group relative to Gold stage II, III, and IV
groups. In addition, the lack of a significant decrease in
EBC iron can possibly reflect the smaller number in
this group relative to the total number of smokers in
the study (i.e. the number included in smoker controls
andGold II, III, and IV groups).
Results from this and other studies support a
decreased level of iron in the ELF in smokers. This
contrasts with other approaches which have revealed
increased iron concentrations among smokers. Diges-
tion of lung tissue from smokers demonstrated ele-
vated concentrations of non-heme iron [30]. Prior
investigation employing bronchoalveolar lavage sup-
ported increased iron concentrations in the ELF (i.e.
the alveolar and airway lining fluids) of smokers
[10, 11]. Lung tissue includes iron complexed by the
particle.While total tissue and cell iron concentrations
are increased, metal concentrations in the ELF appear
to be diminished through the same pathway of iron
complexation by the endocytosed particle. This is
comparable to exposures to numerous compounds
which demonstrate a capacity to complex metal and
subsequently total cell iron can be increased but avail-
ablemetal concentrations are decreased [31].
In previous investigation, there were lower levels
of iron (and copper) in EBC obtained from patients
with stable COPD patients relative to samples col-
lected from healthy subjects and healthy smokers
while lead, cadmium, and aluminumwere higher [12].
Using a bleomycin assay, another study revealed that
EBC iron concentrations were decreased among
patients diagnosed to have COPD relative to smokers
with no obstruction [13]. These decrements in EBC
iron were attributed to a failure of the diseased lung to
excrete iron [13]. In our cohort of samples, COPDwas
associated with decreased iron concentration in the
EBC comparable to these other studies. While the
impact of smoking on EBC iron varies among prior
studies, the diagnosis of COPD has repeatedly been
associated with lower EBC iron concentrations.
Rather than a failure to excrete iron, these results likely
reflect an increased burden of cigarette smoke particle,
including HULIS, in the lower respiratory tract of
patients with COPD [13]. As the particle accumulates
with greater smoking, host iron homeostasis is dis-
rupted and, despite an accumulation of this metal in
the lung, a functional iron deficiency develops. Loss of
pulmonary function among smokers has been shown
to correlate with the disruption in iron homeostasis
(e.g. FEV1/FVC decreases as serum ferritin increases)
supporting such a pathway [32].
A limitation of this investigation is that the metal
concentrations are expressed in units of absolute con-
centration and not normalized to some index to
account for dilution (e.g. protein). However, it was
elected to communicate results in parts per billion
Figure 3.Correlations of EBC concentrations of iron and zinc. There was a significant increase in EBC zincwith EBC iron
(p<.0001).
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without normalization for purposes of comparison to 
other studies focused on EBC metal levels in COPD 
which had reported the same end-points as absolute 
concentrations.
It is concluded that smoking and a diagnosis of 
COPD both decrease EBC iron concentrations. These 
results likely reflect an increased burden of cigarette 
smoke particle in the lower respiratory of smokers and 
patients with COPD and the capacity of components 
of this particle to complex iron.
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